Telo Genomics Corp (TELO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3 | 3 | 3 | 3 | 5 |
| Accounts receivable | 10 | 4 | -1 | -12 | 14 |
| Other Working Capital | 238 | 129 | -374 | 205 | 80 |
| Other Operating Activity | -551 | -596 | -624 | -602 | -567 |
| Operating Cash Flow | $-301 | $-459 | $-996 | $-406 | $-468 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | 0 | -3 | 0 | 0 |
| Investing Cash Flow | $-2 | $0 | $-3 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 2,326 | 0 |
| Financing Cash Flow | $N/A | $0 | $0 | $2,326 | $0 |
| Beginning Cash Position | 789 | 1,249 | 2,248 | 328 | 796 |
| End Cash Position | 487 | 789 | 1,249 | 2,248 | 328 |
| Net Cash Flow | $-303 | $-459 | $-1,000 | $1,920 | $-468 |
| Free Cash Flow | |||||
| Operating Cash Flow | -301 | -459 | -996 | -406 | -468 |
| Capital Expenditure | -2 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -303 | -459 | -996 | -406 | -468 |